Centro de Investigaciones Cardiovasculares, CONICET-La Plata, Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.
J Mol Cell Cardiol. 2011 Dec;51(6):936-44. doi: 10.1016/j.yjmcc.2011.08.010. Epub 2011 Aug 19.
To explore whether CaMKII-dependent phosphorylation events mediate reperfusion arrhythmias, Langendorff perfused hearts were submitted to global ischemia/reperfusion. Epicardial monophasic or transmembrane action potentials and contractility were recorded. In rat hearts, reperfusion significantly increased the number of premature beats (PBs) relative to pre-ischemic values. This arrhythmic pattern was associated with a significant increase in CaMKII-dependent phosphorylation of Ser2814 on Ca(2+)-release channels (RyR2) and Thr17 on phospholamban (PLN) at the sarcoplasmic reticulum (SR). These phenomena could be prevented by the CaMKII-inhibitor KN-93. In transgenic mice with targeted inhibition of CaMKII at the SR membranes (SR-AIP), PBs were significantly decreased from 31±6 to 5±1 beats/3min with a virtually complete disappearance of early-afterdepolarizations (EADs). In mice with genetic mutation of the CaMKII phosphorylation site on RyR2 (RyR2-S2814A), PBs decreased by 51.0±14.7%. In contrast, the number of PBs upon reperfusion did not change in transgenic mice with ablation of both PLN phosphorylation sites (PLN-DM). The experiments in SR-AIP mice, in which the CaMKII inhibitor peptide is anchored in the SR membrane but also inhibits CaMKII regulation of L-type Ca(2+) channels, indicated a critical role of CaMKII-dependent phosphorylation of SR proteins and/or L-type Ca(2+) channels in reperfusion arrhythmias. The experiments in RyR2-S2814A further indicate that up to 60% of PBs related to CaMKII are dependent on the phosphorylation of RyR2-Ser2814 site and could be ascribed to delayed-afterdepolarizations (DADs). Moreover, phosphorylation of PLN-Thr17 and L-type Ca(2+) channels might contribute to reperfusion-induced PBs, by increasing SR Ca(2+) content and Ca(2+) influx.
为了探究 CaMKII 依赖性磷酸化事件是否介导再灌注心律失常,Langendorff 灌流心脏经历了整体缺血/再灌注。记录心外膜单相或跨膜动作电位和收缩性。在大鼠心脏中,与缺血前值相比,再灌注显著增加了过早搏动 (PBs) 的数量。这种心律失常模式与肌浆网 (SR) 上 Ca(2+)释放通道 (RyR2) 的 Ser2814 和磷蛋白 (PLN) 的 Thr17 上 CaMKII 依赖性磷酸化的显著增加相关。这些现象可以被 CaMKII 抑制剂 KN-93 预防。在靶向抑制 SR 膜上的 CaMKII 的转基因小鼠 (SR-AIP) 中,PBs 从 31±6 显著减少到 5±1 次/3min,早期后除极 (EADs) 几乎完全消失。在 RyR2 上的 CaMKII 磷酸化位点发生基因突变的小鼠 (RyR2-S2814A) 中,PBs 减少了 51.0±14.7%。相比之下,在 PLN 磷酸化位点均被消融的转基因小鼠 (PLN-DM) 中,再灌注时 PBs 的数量没有变化。在 SR-AIP 小鼠中的实验中,CaMKII 抑制肽锚定在 SR 膜上,但也抑制 CaMKII 对 L 型 Ca(2+)通道的调节,表明 SR 蛋白和/或 L 型 Ca(2+)通道的 CaMKII 依赖性磷酸化在再灌注心律失常中起着关键作用。在 RyR2-S2814A 中的实验进一步表明,多达 60%与 CaMKII 相关的 PBs 依赖于 RyR2-Ser2814 位点的磷酸化,并且可以归因于延迟后除极 (DADs)。此外,PLN-Thr17 和 L 型 Ca(2+)通道的磷酸化可能通过增加 SR Ca(2+) 含量和 Ca(2+)内流,导致再灌注诱导的 PBs。